WNT11 and neoplasm: To better conceptualize the heterogeneity in WNT11-driven immune resistance across different liver metastasis origins, we propose a tumor–immune–signaling matrix (Figure 4), integrating primary tumor source, immune phenotypes, and dominant WNT11 downstream effectors.